Interleukin-10-treated human dendritic cells induce a melanoma-antigen : specific anergy in CD8+ T cells resulting in a failure to lyse tumor cells
Blood. Bd. 93. H. 5. Stanford, Calif.: HighWire Press 1999 S. 1634 - 1642
Erscheinungsjahr: 1999
ISBN/ISSN: 0006-4971
Publikationstyp: Zeitschriftenaufsatz (Forschungsbericht)
Sprache: Englisch
| Geprüft: | Bibliothek |
Inhaltszusammenfassung
Dendritic cells (DC) are critically involved in the initiation of primary immune processes, including tumor rejection. In our study, we investigated the effect of interleukin-10 (IL-10)-treated human DC on the properties of CD8( ) T cells that are known to be essential for the destruction of tumor cells. We show that IL-10-pretreatment of DC not only reduces their allostimulatory capacity, but also induces a state of alloantigen-specific anergy in both primed and naive (CD45RA ) CD8( ) T cell...Dendritic cells (DC) are critically involved in the initiation of primary immune processes, including tumor rejection. In our study, we investigated the effect of interleukin-10 (IL-10)-treated human DC on the properties of CD8( ) T cells that are known to be essential for the destruction of tumor cells. We show that IL-10-pretreatment of DC not only reduces their allostimulatory capacity, but also induces a state of alloantigen-specific anergy in both primed and naive (CD45RA ) CD8( ) T cells. To investigate the influence of IL-10-treated DC on melanoma-associated antigen-specific T cells, we generated a tyrosinase-specific CD8( ) T-cell line by several rounds of stimulation with the specific antigen. After coculture with IL-10-treated DC, restimulation of the T-cell line with untreated, antigen-pulsed DC demonstrated peptide-specific anergy in the tyrosinase-specific T cells. Addition of IL-2 to the anergic T cells reversed the» weiterlesen» einklappen
Autoren
Klassifikation
DFG Fachgebiet:
2.21 - Mikrobiologie, Virologie und Immunologie
DDC Sachgruppe:
Medizin